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SCREENING FOR PHENYLKETONURIA IN 
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ABSTRACT 
This study was aimed to screen the patients for phenylketonuria among chronic psychiatric 
inpatients. A total of 577 cases were studied which included mentally retarded patients, schizophrenics 
and those suffering from depressive disorders. During the extensive screening not a single positive 
case could be identified. The findings of this screening support the previous studies. Looking at low 
incidence of PKU we do not recommend extensive screening for PKU. 
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maximum phenylalanine and tyrosine 
concentrations in tissues and in brain. Liver 
phenylalanine hydroxylase regulates the levels 
of phenylalanine and tyrosine. 
The breakdown of concentration 
boundaries and the consequent devastating 
effects on brain development are well 
documented in classic PKU, in which liver 
phenylalanine hydroxylase is nonfunctional 
because of mutation. 
Phenylalnine 
L-Phenylalnine ^ L-Tyrosine 
Phenylketonuria (PKU) designate a group 
of inborn error of metabolism of phenylalanine 
that share the common feature of impaired 
phenylalnine oxidation, which results in elevated 
tissue and serum phenylalanine. 
Phenylketonuria is a disorder of amino 
acid metabolism that leads to 
hyperphenylalaninemia, mental retardation and 
several psychiatric symptoms that resemble 
autism or schizophrenia (Jervis,1963). 
Phenylalanine is an essential amino acid 
for protein synthesis in mammalian tissues. The 
proportion of dietary phenylalanine that is utilized 
for protein synthesis varies with age. It is about 
50% of the daily intake during early growth and 
decreases as the growth rate declines. 
Physiologically, the most significant 
pathway of phenylalanine metabolism is through 
hydroxylation to tyrosine. The reverse reaction 
i.e. tyrosine to phenylalnine, does not take place 
even in phenylalanine deficient state. This 
hydroxylation is limited to the liver, kidney and 
pancreas in mammalian tissues. Tyrosine, the 
product of hydroxylation is an essential amino 
acid and a precursor of such biogenic amines 
as dopamine and norepinephrine. 
Membrane transport of amino acids and 
synthesis of protein require critical minimum and 
Hydroxylase 
The absence or deficiency of 
phenylalanine hydroxylase does not permit this 
normal reaction and lead to accumulation of 
phenylpyruvic acid and phenylethylamine in 
serum and their excretion in urine. 
Table showing major features of 
phenylketonuria : 
Clinical aspect 
Defect 
Blood phenylalnine 
Blood Tyrosine 
Urine 
Treatment 
Mental Retardation & 
associated symptoms if untreated 
Phenylalanine hydroxylase 
absent/deficient 
>20 mg/100 ml on regular diet 
Normal to low 
Elevated phenylalanine metabolites 
Low phenylalanine diet 
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A schematic and simplified metabolic pathway of phenylalanine. Notice, there may be more than one enzymatic 
step interposed between most of the conversions indicated by the arrows. 
MATERIAL AND METHOD 
The sample size for screening consisted 
of 577 patients out of which 351 were suffering 
from mental retardation, 112 from schizophrenia 
and 114 from depression, of those which visited 
to Government Medical College, Nagpur and 
Mental Hospital, Nagpur. 
Ferric chloride test was carried out to 
screen phenylketonuria. 
Ferric Chloride Test (Gowenlock,1968): A few 
drops of 10% ferric chloride solution were added 
to 5 ml of the urine in a test tube. Phenylpyruvic 
acid gives a green or blue colour for one to two 
minutes; it then gradually fades. Phenylpyruvic 
acid may disappear quite rapidly in alkaline urine 
by oxidation. So the test was carried out on fresh 
urine. p-Hydroxyphenyl pyruvic acid which is 
present in more than one percent of the urines 
of young infants gives a similar colour. 
In our study, we have not come across, 
even a single patient of phenylketonuria. 
DISCUSSION 
There have been several case reports of 
unrecognized PKU in adult psychiatric patients, 
some of whom were not retarded (Perry et 
al.,1973; Fisch etal.,1979). Such findings, even 
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if rare, are extremely important, since even PKU 
that has not been recognized until adulthood may 
be partially treatable with a low phenylalanine 
diet (Marholin et al.,1978). The case reports also 
raise the issue of whether adult psychiatric 
inpatient populations should be screened for 
PKU. 
At least three screening programs from 
adult psychiatric inpatients have been reported. 
Cares (1956), screened 4,246 inpatients of a 
state mental hospital using the ferric chloride test 
on urine and more recently Willett et al.(1980) 
screened 635 consecutive admissions to state 
mental hospital by testing urine with the dry 
reagent ferric ammonium sulfate. Neither survey 
detected any patients with PKU. Reveley and 
Reveley (1982), who also used a urine test 
relying on ferric salts, found no cases of PKU 
among 586 inpatients. 
The prevalence of PKU is known to vary 
directly with the severity of mental retardation. 
Its prevalence in the educable mentally retarded 
is between 1/750 and 1/2,363 (Williamson et al., 
1968). In contrast, the prevalence of PKU among 
the severely retarded is about 1/72 (Henderson 
etal.,1961). 
All these serveys are conducted in foreign 
states and not a single survey has been 
conducted so far in India, to best of our 
knowledge. This led us to conduct this study. 
However, use of any ferric salt as the 
screening test might not have detected all 
patients with PKU, because antipsychotics 
excreted in the urine can interfere with the colour 
change produce by a positive ferric salt test 
(Allen etal.,1964). 
Because of the low prevalence of PKU in 
this psychiatric population, extensive screening 
programs are probably not necessary. However, 
even though descriptive data are not available 
for the patients, we believe, that there are specific 
clinical indications for carying out the test on 
psychiatric patients, including mental retardation, 
a family history of PKU, or a DSM-III diagnosis of 
any of the pervasive developmental disorders 
(Szymanski et al., 1984). 
Patients with pervasive developmental 
disorders may be particularly important to test, 
given the findings of Lowe et al.(1980), that three 
of 65 such children had unrecognized PKU, 
patients with schizophrenia or an unexplained 
seizure disorder who also have eczema or light 
hair colour (where both parents are dark haired) 
should also be considered for testing. Patients 
who have any of the above characteristics are 
particularly at risk for unrecognized PKU. We 
therefore, do not plead for extensive screening 
for PKU further more. 
REFERENCES 
Allen.R.J. & Wilson,J.L.(1964) Urinary 
phenylpyruvic acid in phenylketonuria. The 
Journal of American Medical Association, 188, 
102-106. 
Cares, R.M. (1956) Absence of 
phenylketonuria in adult psychotics. American 
Journal of Psychiatry, 112, 938-939. 
Fisch.D.O., Hosfield.W.B. & Chang.P.N. 
(1979) An adult phenylkemuric with 
schizophrenia. Minnesota Medicine, 62,243-246. 
Gowenlock,A.H.(1968) Ferric chloride 
test. In : Practical Clinical Biochemistry, Edn.4, 
(Ed.) Varley.G.N., pp 385. 
Henderson,R.A. & Centerwall.W.R. 
(1961) The attack on phenylketonuria : a pilot 
study. Exceptional Children, 27, 260-263. 
Jervis,G.A.(1963) The clinical picture. In: 
Phenylketonuria, Edn.3, (Eds.) Lyman,F.L., 
Springfield.T.S. & Thomas.R.N., pp 23-24. 
Lowe.T.L., Tanaka.K. & Seashore,M.R. 
(1980) Detection of phenylketonuria in autistic 
and psychotic children. The Journal of The 
American Medical Association, 243, 126-128. 
Marholin,D., Pohl.R. & Steward.R.M. 
(1978) Effects of diet and behaviour therapy on 
social and motor behaviour of retarded 
366 SCREENING FOR PHENYLKETONURIA 
phenylketonuric adults : An experimental 
analysis. Pediatric Research, 12, 179-187. 
Perry.T.L., Hansen,S. & Tischler.B. 
(1973) Unrecognized adult phenylketonuria : 
implications for obstetrics and psychiatry. New 
England Journal of Medicine, 289, 395-398. 
Reveley.A.M. & Reveley,M.A.(1982) 
Screening for adult phenylketonuria in psychiatric 
inpatients. Biological Psychiatry, 17,1343-1345. 
Szymanski, H.V., Friedman, S. & 
A.K.TADAS'.M.D.(Biochemistry), Lecturer, I.C. APTE, Ph. 
Ph. D. (Biochemistry), Professor & Head, Department ofBkxh 
* Correspondence 
Guthrie.R. (1984) Screening for phenylketonuria 
in psychiatric inpatients. Hospital and Community 
Psychiatry, 35, 936-938. 
Willett.A.B., Nelson,J.E. & Foss.O.K. 
(1980) Screening for adult phenylketonuria in 
state psyciatric hospitals. American Journal of 
Psychiatry, 137,1607-1608. 
Williamson, M.S., Koch, R. & 
Henderson, R. (1968) Phenylketonuria in school 
age retarded children. American Journal of 
Mental Deficiency, 72, 740-747. 
l(Biochemistry), Associate Professor & P.L. KAMLAKAR, 
nistry, Government Medical College, Nagpur. 
367 